No record found
* Returns not adjusted for payouts
Company Profile
The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993, the Company was converted into a public limited company under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company, which holds 56.32% shareholding in the Company.
Syed Nadeem Ahmed | CEO |
Adnan Asdar Ali | Chairperson |
Zubair Razzak Palwala | Company Secretary |
One IBL Centre 2nd Floor, Plot # 1, Block 7 & 8 D.M.C.H.S, Tipu Sultan Road Off Shahrah-e-Faisal, Karachi
CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi
A. F. Ferguson & Co. Chartered Accountants
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 31, 2024 | Transmission of Quarterly Report for the Period Ended 2024-09-30 | View PDF |
Oct 30, 2024 | Financial Results for the Quarter Ended 2024-09-30 | View PDF |
Oct 18, 2024 | Transmission of Annual Report for the Year Ended 2024-06-30 | View PDF |
Oct 7, 2024 | Financial Results for the Year Ended 2024-06-30 | View PDF |
May 3, 2024 | Transmission of Quarterly Report for the Period Ended 2024-03-31 | View PDF |
Apr 30, 2024 | Financial Results for the Quarter Ended 2024-03-31 | View PDF |
Mar 4, 2024 | Transmission of Quarterly Report for the Period Ended 2023-12-31 | View PDF |
Mar 1, 2024 | Financial Results for the Quarter Ended 2023-12-31 | View PDF |
Nov 1, 2023 | Transmission of Quarterly Report for the Period Ended 2023-09-30 | View PDF |
Oct 27, 2023 | Financial Results for the Quarter Ended 2023-09-30 | View PDF |
Date | Title | Document |
---|---|---|
Nov 18, 2024 | Notice of Extraordinary General Meeting | View PDF |
Oct 29, 2024 | CERTIFIED TRUE COPY OF RESOLUTIONS PASSED AT 59TH ANNUAL GENERAL MEETING OF THE SEARLE COMPANY LIMITED | View PDF |
Oct 23, 2024 | Board Meeting | View PDF |
Oct 18, 2024 | Notice of Annual General Meeting | View PDF |
Sep 30, 2024 | Board Meeting | View PDF |
Jul 24, 2024 | Board Meeting Other Than Financial Results | View PDF |
May 8, 2024 | Board Meeting Other Than Financial Results | View PDF |
Apr 24, 2024 | Board Meeting | View PDF |
Apr 9, 2024 | Board Meeting Other Than Financial Results | View PDF |
Feb 22, 2024 | Board Meeting | View PDF |
Date | Title | Document |
---|---|---|
Nov 19, 2024 | Corporate Briefing Session-2024 | View PDF |
Oct 17, 2024 | Clarification/Denial of Fake News Regarding Alleged Interest in Acquiring Stake in Abbot Laboratories | View PDF |
Oct 4, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Oct 4, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View |
Sep 4, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Sep 4, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View |
Aug 22, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Aug 19, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Aug 19, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Aug 15, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jul 31, 2024 | Material Information | View PDF |
Financials
All numbers in thousands (000's) except EPS
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Sales | 25,827,210 | 21,641,282 | 17,737,282 | 16,569,596 |
Profit after Taxation | (3,330,859) | 302,137 | 2,090,717 | 2,122,924 |
EPS | (6.95) | 0.75 | 5.36 | 7.01 |
Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | |
---|---|---|---|---|
Sales | 6,677,620 | 5,786,361 | 5,752,787 | 7,570,264 |
Profit after Taxation | 300,781 | (109,811) | (103,548) | 324,635 |
EPS | 0.59 | (0.21) | (0.22) | 0.80 |
Ratios
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Gross Profit Margin (%) | 48.62 | 44.10 | 48.76 | 51.59 |
Net Profit Margin (%) | (12.90) | 1.40 | 11.79 | 12.81 |
EPS Growth (%) | (1,026.67) | (86.01) | (23.54) | (37.69) |
PEG | 0.01 | (0.59) | (0.86) | (0.92) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
August 8, 2023 2:36 PM | - | 31.13 AT A PREMIUM OF Rs.25/= PER SHARE (R) | 21/08/2023 - 25/08/2023 |
May 25, 2023 3:46 PM | - | 31.13 AT A PREMIUM OF Rs.25/= PER SHARE (R) | - |
October 3, 2022 3:56 PM | 30/06/2022(YR) | 25% (B) | 22/10/2022 - 28/10/2022 |
October 4, 2021 3:40 PM | 30/06/2021(YR) | 20% (D) - 30% (B) | 08/11/2021 - 28/10/2021 |
October 28, 2020 2:51 PM | 30/09/2020(IQ) | 13% AT A PREMIUM OF Rs.160/= PER SHARE (R) | 19/11/2020 - 25/11/2020 |
September 29, 2020 3:41 PM | 30/06/2020(YR) | 25%(F) (D) | 22/10/2020 - 28/10/2020 |
October 1, 2019 11:11 AM | 30/06/2019(YR) | 25%(F) (D) | 19/10/2019 - 25/10/2019 |
October 12, 2018 10:30 AM | 30/06/2018(YR) | 50% (D) - 15% (B) | 16/11/2018 - 22/11/2018 |
September 29, 2017 10:50 AM | 30/06/2017(YR) | 80% (D) - 20% (B) | 21/10/2017 - 27/10/2017 |
February 27, 2017 4:29 PM | 31/12/2016(HYR) | 20% (D) - 10% (B) | 28/03/2017 - 04/04/2017 |